---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-153907"
form_type: "8-K/A"
ticker: "HUMA"
cik: "0001818382"
company_name: "Humacyte, Inc."
filed_at: "2021-12-28T23:59:59+00:00"
generated_at: "2026-06-27T22:10:54.670142+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Humacyte amends 8-K to correct Dr. Lawson departure date from Dec 31 2022 to Dec 31 2021

## Summary
- Original 8-K reported departure of Dr. Jeffrey Lawson as Chief Surgical Officer and board resignation.
- Amendment corrects separation date from December 31, 2022 to December 31, 2021 due to scrivener error.
- No other changes to the original disclosure.

## SEC filing metadata
- accession: 0001104659-21-153907
- form_type: 8-K/A
- ticker: HUMA
- cik: 0001818382
- company_name: Humacyte, Inc.
- filed_at: 2021-12-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818382/000110465921153907/0001104659-21-153907-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818382/000110465921153907/tm2136448d1_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-153907
- JSON: https://secwatch.observer/filing/0001104659-21-153907.json
- Plain text: https://secwatch.observer/filing/0001104659-21-153907.txt

## Key facts
- Executive change
  Jeffrey H. Lawson resigned as Chief Surgical Officer at Humacyte, Inc..
  - Action: resigned
  - Role: Chief Surgical Officer
  source text: This Amendment No. 1 on Form 8-K/A amends the Current Report on Form 8-K of Humacyte, Inc. (the "Original Report"), which reported the departure of Jeffrey H. Lawson, M.D., PhD. as the Company's Chief Surgical Officer and Dr. Lawson's resignation from the Company's board of directors, each effective as of the "separation date."
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818382/000110465921153907/0001104659-21-153907-index.htm
- Executive change
  Jeffrey H. Lawson resigned as Director at Humacyte, Inc..
  - Action: resigned
  - Role: Director
  source text: This Amendment No. 1 on Form 8-K/A amends the Current Report on Form 8-K of Humacyte, Inc. (the "Original Report"), which reported the departure of Jeffrey H. Lawson, M.D., PhD. as the Company's Chief Surgical Officer and Dr. Lawson's resignation from the Company's board of directors, each effective as of the "separation date."
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818382/000110465921153907/0001104659-21-153907-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.